IE 11 is not supported. For an optimal experience visit our site on another browser.

FDA to crack down on unapproved cough meds

U.S. regulators said they were beginning a campaign to crack down on companies selling unapproved versions of an often-abused painkiller with the potent narcotic hydrocodone.
/ Source: Reuters

U.S. regulators on Friday said they were beginning a campaign to crack down on companies selling unapproved versions of an often-abused painkiller with the potent narcotic hydrocodone.

The U.S. Food and Drug Administration said the ingredient, legal in approved drugs like Vicodin, is now widely used and abused in unapproved versions to stem coughing.

The agency said it will take enforcement action against companies marketing unapproved versions, but did not name specific ones. Companies selling the drugs for children under the age of 6 years must stop before Oct. 31, the agency said, because there is no evidence supporting its safe use in this group.

There are seven FDA-approved versions of cough suppressants containing the drug.

The effort is part of a larger FDA strategy to crack down on drugs that slip through the approval process, announced last year.

The agency will have a media briefing later Friday on the issue.